← Open Payments lookup

SARAH HALL: Open Payments

NPI 1346768330 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$830 in 39 payments from 11 companies in 2025. Trend: 2023 $765 · 2024 $1,049 · 2025 $830

Food & beverage: $830
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.16$299
Teva Pharmaceuticals USA, Inc.4$151
Otsuka America Pharmaceutical, Inc.4$77
Janssen Pharmaceuticals, Inc3$69
Vanda Pharmaceuticals Inc.3$63
Janssen Scientific Affairs, LLC2$45
Alkermes, Inc.2$39
E.R. Squibb & Sons, L.L.C.2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Takeda Pharmaceuticals U.S.A., Inc.1$17

Products named: INGREZZA, UZEDY, INVEGA SUSTENNA, FANAPT, REXULTI, ARISTADA, COBENFY, ABILIFY ASIMTUFII.

Industry payments across ID — which companies pay providers there.